Novartis wins approval for Voltaren, treatment for osteoarthritis

BASEL, Switzerland - Swiss pharmaceutical company Novartis AG said Monday its Voltaren Gel received U.S. regulatory approval as the first topical prescription treatment for pain associated with osteoarthritis. The U.S....More